NEW YORK, Oct. 3 – Oncogenomics company Sagres Discovery said Wednesday it had raised $20 million in a second round of private financing.
Sagres of Davis, Calif., said it would use the fresh influx of funds to develop its collection of genes associated with cancer and to form deals with partners to develop antibody and small molecule treatments. The company is also planning to build its senior management and pre-clinical research teams.